THE PROGNOSTIC VALUE OF ELEVATED MONOCYTE-TO-LYMPHOCYTE RATIO AND LACTATE DEHYDROGENASE IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS

THE PROGNOSTIC VALUE OF ELEVATED MONOCYTE-TO-LYMPHOCYTE RATIO AND LACTATE DEHYDROGENASE IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS

Multiple myeloma (MM) is a malignant blood cancer characterized by proliferation of plasma cells in bone marrow that is mainly composed by inflammatory cells. A prognostic effect can be assessed as consequence of alterations in peripheral blood leukocytes and the ratio between blood cells have been...

Full description

Bibliographic Details
Main Authors:	LF Corral, L Kowalczuk, C Bundchen, SC Wagner, LN Rotta
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137923009355

Similar Items

The (Neutrophils + Monocyte)/Lymphocyte Ratio Is an Independent Prognostic Factor for Progression-Free Survival in Newly Diagnosed Multiple Myeloma Patients Treated With BCD Regimen
by: Yanbin Pang, et al.
Published: (2020-09-01)

FATORES ENVOLVIDOS NA DECISÃO DE DOAR OU NÃO SANGUE POR ACADÊMICOS DA ÁREA DA SAÚDE
by: L Medeiros, et al.
Published: (2023-10-01)

Clinical importance of the absolute count of neutrophils, lymphocytes, monocytes, and platelets in newly diagnosed hepatocellular carcinoma
by: Jeong Il Yu, et al.
Published: (2021-01-01)

Acquired platelet dysfunction in newly diagnosed myeloma
by: Joshua Mortimer, et al.
Published: (2021-02-01)

Daratumumab in untreated newly diagnosed multiple myeloma
by: Nadine Abdallah, et al.
Published: (2019-12-01)

PB2136: THE VALUE OF PERIPHERAL BLOOD LYMPHOCYTE SUBSETS IN PREDICTING THE PROGNOSIS OF NEWLY DIAGNOSED MULTIPLE MYELOMA
by: Zhaoyun Liu, et al.
Published: (2023-08-01)

Ratio of Monocytes to Lymphocytes in Peripheral Blood in Children Diagnosed with Active Tuberculosis
by: Ayça Demir, et al.
Published: (2020-06-01)

Ratio of monocytes to lymphocytes in peripheral blood in patients diagnosed with active tuberculosis
by: Jun Wang, et al.
Published: (2015-03-01)

Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12
by: Francesco Autore, et al.
Published: (2019-06-01)

Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker
by: Asmaa M. Zahran, et al.
Published: (2021-08-01)

Elevated lactate dehydrogenase predicts pneumonia in spontaneous intracerebral hemorrhage
by: Yangchun Xiao, et al.
Published: (2024-02-01)

Elevated levels of monocyte-lymphocyte ratio and platelet-lymphocyte ratio in adolescents with non-suicidal self-injury
by: Qi Zheng, et al.
Published: (2022-09-01)

Regulatory Effect and Mechanism of Erythroblastic Island Macrophages on Anemia in Patients with Newly Diagnosed Multiple Myeloma
by: Huang H, et al.
Published: (2023-06-01)

Eastern Cooperative Oncology Group, β2-microglobulin, hemoglobin, and lactate dehydrogenase can predict early grade ≥ 3 infection in patients with newly diagnosed multiple myeloma: A real-world multicenter study
by: Xinyi Lu, et al.
Published: (2023-01-01)

Clinical significance of granule‐containing myeloma cells in patients with newly diagnosed multiple myeloma
by: Kazuhito Suzuki, et al.
Published: (2016-11-01)

Corrigendum: Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker
by: Asmaa M. Zahran, et al.
Published: (2022-03-01)

The neutrophil-to-lymphocyte ratio and lactate dehydrogenase combined in predicting liver metastasis and prognosis of colorectal cancer
by: Qin Chen, et al.
Published: (2023-06-01)

Muscle and fat composition in patients with newly diagnosed multiple myeloma
by: Nadine H. Abdallah, et al.
Published: (2023-12-01)

Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas
by: Martin Stork, et al.
Published: (2022-10-01)

Evaluation of the clinico-laboratory manifestations of newly diagnosed multiple myeloma
by: Angela Ogechukwu Ugwu
Published: (2022-01-01)

Efficacy and tolerability of bortezomib and dexamethasone in newly diagnosed multiple myeloma
by: Mir Sadaqat Hassan Zafar, et al.
Published: (2018-01-01)

HOW I TREAT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS?
by: María-Victoria Mateos
Published: (2021-11-01)

Changing landscape of induction therapy in newly diagnosed multiple myeloma
by: Nidhi Tandon, et al.
Published: (2019-01-01)

Elevated lactate dehydrogenase predicts poor prognosis of acute ischemic stroke.
by: Xia-Xia Jin, et al.
Published: (2022-01-01)

Detection of senescent CD8+ T-lymphocyte in newly diagnosed and relapsed/refractory multiple myeloma using CD28 and CD57
by: Zahraa Mahdi Sareeh, et al.
Published: (2023-01-01)

Lactate dehydrogenase-elevating virus induces systemic lymphocyte activation via TLR7-dependent IFNalpha responses by plasmacytoid dendritic cells.
by: Christoph G Ammann, et al.
Published: (2009-07-01)

Changes in RDW according to prognostic predictors in newly diagnosed multiple myeloma
by: Melania Carlisi, et al.
Published: (2024-02-01)

The Clinical Relevance of Selected Cytokines in Newly Diagnosed Multiple Myeloma Patients
by: Michał Mielnik, et al.
Published: (2023-11-01)

A simple additive staging system for newly diagnosed multiple myeloma
by: Nadine H. Abdallah, et al.
Published: (2022-01-01)

Clinical Significance of TP53 Abnormalities in Newly Diagnosed Multiple Myeloma
by: Fang Ye, et al.
Published: (2021-12-01)

The choice of regimens based on bortezomib for patients with newly diagnosed multiple myeloma.
by: Jingsong He, et al.
Published: (2014-01-01)

The potential of CBC-derived ratios (monocyte-to-lymphocyte, neutrophil-to-lymphocyte, and platelet-to-lymphocyte) to predict or diagnose incident TB infection in Tanzanian adolescents
by: Christiaan A. Rees, et al.
Published: (2020-08-01)

Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio in Patients With Newly Diagnosed Moyamoya Disease: A Cross-Sectional Study
by: Wenyuan Ma, et al.
Published: (2021-11-01)

Evaluation of the Relationship Between Lactate Dehydrogenase/Lymphocyte Ratio with Interleukin-6 Levels in Hospitalized Patients with COVID-19
by: Umay BALCI, et al.
Published: (2021-12-01)

Prognostic value of neutrophile-to-lymphocyte ratio (NLR) and lactate dehydrogenase (LDH) levels for geriatric patients with COVID-19
by: Uğur Önal, et al.
Published: (2022-04-01)

A new parameter in COVID-19 pandemic: initial lactate dehydrogenase (LDH)/Lymphocyte ratio for diagnosis and mortality
by: Istemi Serin, et al.
Published: (2020-11-01)

EFFECTS OF DARATUMUMAB (DARA), CYCLOPHOSPHAMIDE (C), THALIDOMIDE (T) AND DEXAMETHASONE (D) COMBINATION ON LYMPHOCYTE POPULATIONS OF TRANSPLANT ELIGIBLE NEWLY DIAGNOSE MULTIPLE MYELOMA PATIENTS
by: A Santos, et al.
Published: (2021-10-01)

The Role of Monoclonal Antibodies in Smoldering and Newly Diagnosed Transplant-Eligible Multiple Myeloma
by: Elena Zamagni, et al.
Published: (2020-12-01)

Epigenetic Deregulation of Telomere-Related Genes in Newly Diagnosed Multiple Myeloma Patients
by: Samrat Roy Choudhury, et al.
Published: (2021-12-01)

Body Mass Index and Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
by: Bei Wang, et al.
Published: (2022-10-01)